Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 27;83(4):383-389.
doi: 10.1055/s-0041-1735588. eCollection 2022 Aug.

Perioperative Outcomes of a Hydrocortisone Protocol after Endonasal Surgery for Pituitary Adenoma Resection

Tyler D Alexander  1 , Sarah Collopy  1 , Siyuan Yu  1 , Michael Karsy  1 , Chandala Chitguppi  2 , Christopher J Farrell  1 , James J Evans  1
Affiliations

Perioperative Outcomes of a Hydrocortisone Protocol after Endonasal Surgery for Pituitary Adenoma Resection

Tyler D Alexander et al. J Neurol Surg B Skull Base. .

Abstract

Introduction In pituitary adenomas (PAs), the use of postoperative steroid supplementation remains controversial, as it reduces peritumoral edema and sinonasal complaints but disrupts the detection of adrenal insufficiency (AI). It is unclear whether postoperative cortisol supplementation has a measurable effect on improving outcomes in patients with pituitary adenoma undergoing endoscopic transsphenoidal surgery (ETS). The objective of the study was to evaluate a postoperative steroid treatment protocol on various surgical outcomes in patients with PA undergoing ETS. Methods A retrospective cohort study was performed for patients undergoing ETS from 2005 to 2020 for PA at a single tertiary academic center. Patients were divided into two groups: those managed by a routine postoperative glucocorticoid supplementation protocol (steroid protocol) and those who received supplementation based on postoperative cortisol laboratory assessment (steroid sparing protocol). Management was otherwise the same between groups. Evaluation of length of stay (LOS), sinonasal outcomes, 30-day readmission, and perioperative complications, including AI, were performed. Results Among 535 patients, 21% ( n = 111) received postoperative steroids, while the remainder ( n = 424) did not. There were no differences in mean LOS (3 vs. 3 days, p = 0.72), sinonasal complaints (27 vs. 19%, p = 0.12), 30-day readmission (5% vs. 5%, p = 0.44), and perioperative complications (5 vs. 5%, p = 0.79) between both the groups. A multivariate model supported that both groups were comparable in predicting LOS, 30-day readmission, and complications. No reduction in readmission for AI was seen. Conclusion Routine administration of postoperative glucocorticoids did not significantly improve patient outcomes in patients with PA who underwent ETS.

Keywords: adenoma; adrenal crisis; adrenal insufficiency; cortisol; hydrocortisone; hypothalamic–pituitary–adrenal axis; outcome; pituitary; tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Similar articles

See all similar articles

Cited by

References

    1. Fernández-Balsells M M, Murad M H, Barwise A. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2011;96(04):905–912. - PubMed
    1. Gittleman H, Ostrom Q T, Farah P D. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009. J Neurosurg. 2014;121(03):527–535. - PubMed
    1. Ezzat S, Asa S L, Couldwell W T. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004;101(03):613–619. - PubMed
    1. Freda P U, Post K D.Differential diagnosis of sellar masses Endocrinol Metab Clin North Am 1999280181–117., vi - PubMed
    1. Gsponer J, De Tribolet N, Déruaz J P. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine (Baltimore) 1999;78(04):236–269. - PubMed